iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/12736744/
Molecular pathogenesis of head and neck squamous cell carcinoma - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2003 Oct;260(9):502-8.
doi: 10.1007/s00405-003-0581-3. Epub 2003 May 8.

Molecular pathogenesis of head and neck squamous cell carcinoma

Affiliations
Review

Molecular pathogenesis of head and neck squamous cell carcinoma

David Hardisson. Eur Arch Otorhinolaryngol. 2003 Oct.

Abstract

Head and neck squamous cell carcinoma (HNSCC) represents 6% of all cancers. The overall 5-year survival rate for patients with this type of cancer is among the lowest of the major cancer types and has not improved dramatically during the last decade. The pathological staging, in particular the nodal stage, is the most important factor in HNSCC. The lack of progress in head and neck oncology emphasizes the importance of molecular genetic studies to define alterations that may correlate with tumor behavior. The molecular alterations observed in HNSCC are mainly due to oncogene activation and tumor suppressor gene inactivation, leading to deregulation of cell proliferation. These alterations include gene amplification and overexpression of oncogenes such as ras, myc, EGFR and cyclin D1, and mutations and deletions leading to p16 and TP53 tumor suppressor genes inactivation. This article reviews the molecular changes commonly observed in HNSCC. The biological function of these markers and the potential clinical application are discussed. Advances in the understanding of the molecular basis of HNSCC will help in the identification of new molecular markers that could be used for a more accurate diagnosis and assessment of prognosis and may open the way for novel approaches to treatment and prevention.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Clin Pathol. 1997 Jun;50(6):509-12 - PubMed
    1. Cancer. 1997 Mar 15;79(6):1114-21 - PubMed
    1. Cancer. 1997 Jan 15;79(2):380-9 - PubMed
    1. Clin Cancer Res. 1999 Sep;5(9):2455-63 - PubMed
    1. Cancer Res. 1991 Dec 1;51(23 Pt 1):6328-37 - PubMed

MeSH terms

LinkOut - more resources